BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 19706803)

  • 1. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
    Comstock CE; Augello MA; Benito RP; Karch J; Tran TH; Utama FE; Tindall EA; Wang Y; Burd CJ; Groh EM; Hoang HN; Giles GG; Severi G; Hayes VM; Henderson BE; Le Marchand L; Kolonel LN; Haiman CA; Baffa R; Gomella LG; Knudsen ES; Rui H; Henshall SM; Sutherland RL; Knudsen KE
    Clin Cancer Res; 2009 Sep; 15(17):5338-49. PubMed ID: 19706803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
    Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
    Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
    Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CCND1 G/A870 polymorphism, allele-specific amplification, cyclin D1 expression, and survival in esophageal and lung carcinoma.
    Gupta VK; Feber A; Xi L; Pennathur A; Wu M; Luketich JD; Godfrey TE
    Clin Cancer Res; 2008 Dec; 14(23):7804-12. PubMed ID: 19047108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
    Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
    Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1b protein expression in breast cancer is independent of cyclin D1a and associated with poor disease outcome.
    Millar EK; Dean JL; McNeil CM; O'Toole SA; Henshall SM; Tran T; Lin J; Quong A; Comstock CE; Witkiewicz A; Musgrove EA; Rui H; Lemarchand L; Setiawan VW; Haiman CA; Knudsen KE; Sutherland RL; Knudsen ES
    Oncogene; 2009 Apr; 28(15):1812-20. PubMed ID: 19287456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
    Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation.
    Solomon DA; Wang Y; Fox SR; Lambeck TC; Giesting S; Lan Z; Senderowicz AM; Conti CJ; Knudsen ES
    J Biol Chem; 2003 Aug; 278(32):30339-47. PubMed ID: 12746453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of CCND1 G870A polymorphism on the risk of HBV-related HCC and cyclin D1 splicing variant expression in Chinese population.
    Zeng Z; Tu J; Cheng J; Yao M; Wu Y; Huang X; Xie X; Zhang X; Lu F; Chen X
    Tumour Biol; 2015 Sep; 36(9):6891-900. PubMed ID: 25851350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
    Augello MA; Burd CJ; Birbe R; McNair C; Ertel A; Magee MS; Frigo DE; Wilder-Romans K; Shilkrut M; Han S; Jernigan DL; Dean JL; Fatatis A; McDonnell DP; Visakorpi T; Feng FY; Knudsen KE
    J Clin Invest; 2013 Jan; 123(1):493-508. PubMed ID: 23257359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
    Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
    Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative levels of cyclin D1a and D1b alternative transcripts in mantle cell lymphoma may depend more on sample origin than on CCND1 polymorphism.
    Carrère N; Belaud-Rotureau MA; Dubus P; Parrens M; de Mascarel A; Merlio JP
    Haematologica; 2005 Jun; 90(6):854-6. PubMed ID: 15951302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck.
    Holley SL; Parkes G; Matthias C; Bockmühl U; Jahnke V; Leder K; Strange RC; Fryer AA; Hoban PR
    Am J Pathol; 2001 Nov; 159(5):1917-24. PubMed ID: 11696452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1: polymorphism, aberrant splicing and cancer risk.
    Knudsen KE; Diehl JA; Haiman CA; Knudsen ES
    Oncogene; 2006 Mar; 25(11):1620-8. PubMed ID: 16550162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcome.
    Abramson VG; Troxel AB; Feldman M; Mies C; Wang Y; Sherman L; McNally S; Diehl A; Demichele A
    Anticancer Res; 2010 Apr; 30(4):1279-85. PubMed ID: 20530440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of cyclin D1b expression and CCND1 polymorphism in the pathogenesis of multiple myeloma and mantle cell lymphoma.
    Krieger S; Gauduchon J; Roussel M; Troussard X; Sola B
    BMC Cancer; 2006 Oct; 6():238. PubMed ID: 17022831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene.
    Lu F; Gladden AB; Diehl JA
    Cancer Res; 2003 Nov; 63(21):7056-61. PubMed ID: 14612495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced skin carcinogenesis and lack of thymus hyperplasia in transgenic mice expressing human cyclin D1b (CCND1b).
    Rojas P; Benavides F; Blando J; Perez C; Cardenas K; Richie E; Knudsen ES; Johnson DG; Senderowicz AM; Rodriguez-Puebla ML; Conti CJ
    Mol Carcinog; 2009 Jun; 48(6):508-16. PubMed ID: 18942117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
    Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
    Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.